Combination of siRNA-directed Gene Silencing With Cisplatin Reverses Drug Resistance in Human Non-small Cell Lung Cancer

One of the most challenging aspects of lung cancer therapy is the rapid acquisition of multidrug-resistant (MDR) phenotype. One effective approach would be to identify and downregulate resistance-causing genes in tumors using small interfering RNAs (siRNAs) to increase the sensitivity of tumor cells...

Descripción completa

Detalles Bibliográficos
Autores principales: Ganesh, Shanthi, Iyer, Arun K, Weiler, Jan, Morrissey, David V, Amiji, Mansoor M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3731892/
https://www.ncbi.nlm.nih.gov/pubmed/23900224
http://dx.doi.org/10.1038/mtna.2013.29

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3731892/
https://www.ncbi.nlm.nih.gov/pubmed/23900224
http://dx.doi.org/10.1038/mtna.2013.29

Ejemplares similares